Why Serum Bicarbonate Becomes Low in Liver Failure
In liver failure, serum bicarbonate becomes low primarily due to impaired hepatic lactate metabolism leading to lactic acidosis, combined with impaired renal acidification mechanisms that normally help maintain acid-base balance.
Primary Mechanisms
Impaired Lactate Metabolism
The failing liver cannot adequately metabolize lactate to bicarbonate through gluconeogenesis. When lactate-containing fluids are administered to patients with liver failure, worsening acidosis has been documented 1. This is why bicarbonate is specifically preferred over lactate as a buffer in dialysate and replacement fluids for patients with liver failure 2.
Lactic Acidosis Development
Liver failure creates a state where:
- Lactate accumulates because the liver cannot convert it to glucose and bicarbonate
- Tissue hypoperfusion (common in advanced cirrhosis) further increases lactate production
- The combination depletes bicarbonate stores as the body attempts to buffer the excess acid
Impaired Renal Acidification
Incomplete distal renal tubular acidosis (RTA) occurs in approximately 57% of patients with alcoholic liver disease 3. This impairment:
- Correlates directly with severity of liver dysfunction (higher bilirubin, lower prothrombin time)
- Prevents the kidneys from compensating for metabolic acidosis
- Represents a sign of hepatocellular failure rather than primary kidney disease 3
Clinical Significance
Prognostic Value
Low admission serum bicarbonate in cirrhotic patients independently predicts adverse outcomes 4:
- Progressive increase in complications (acute kidney injury, hepatorenal syndrome, encephalopathy, GI bleeding) as bicarbonate decreases
- Longer hospital length of stay
- Increased ICU admissions
- Higher mortality rates
The relationship is dose-dependent: as bicarbonate category decreases from normal (22-25 mEq/L) through mildly (18-21), moderately (14-17), to severely (<14 mEq/L) decreased levels, complications and mortality progressively increase 4.
Additional Contributing Factors
Diuretic therapy can worsen the situation. Spironolactone, commonly used for ascites management, can induce hyperchloremic metabolic acidosis in cirrhotic patients, with mean bicarbonate dropping from 18.2 to 10.9 mEq/L during treatment 5.
Management Implications
Buffer Selection in Renal Replacement Therapy
Guidelines specifically recommend bicarbonate rather than lactate as the buffer in dialysate and replacement fluids for patients with liver failure (Grade C recommendation) 1, 2. This is a Grade 1B recommendation for patients with circulatory shock and Grade 2B for those with liver failure and/or lactic acidemia 2.
Caution with Bicarbonate Supplementation
While correcting acidosis seems logical, sodium bicarbonate therapy carries risks in liver failure patients 6:
- Sodium and fluid overload (problematic in ascites)
- May increase need for paracentesis
- The optimal bicarbonate target in liver failure may need to be lower than in other conditions to minimize sodium load
Common Pitfall
Do not assume all low bicarbonate in liver patients represents simple metabolic acidosis requiring aggressive correction. Some patients with chronic liver disease have chronic respiratory alkalosis with compensatory low bicarbonate 3. Always check arterial blood gas to distinguish true metabolic acidosis from respiratory compensation before treating.
Monitoring Approach
In patients with liver failure and low bicarbonate:
- Verify with arterial blood gas (pH, pCO2) to confirm metabolic acidosis vs. respiratory compensation
- Check lactate levels to assess degree of lactic acidosis
- Evaluate for contributing factors (diuretics, renal function, tissue perfusion)
- Consider bicarbonate levels as a marker of disease severity and prognosis
- If requiring renal replacement therapy, ensure bicarbonate-based (not lactate-based) solutions are used